Skrzypczak, Tomasz http://orcid.org/0000-0003-4030-9101
Skrzypczak, Anna
Szepietowski, Jacek C. http://orcid.org/0000-0003-0766-6342
Article History
Received: 27 January 2024
Accepted: 8 February 2024
First Online: 24 February 2024
Declarations
:
: Jacek C. Szepietowski has served as an advisor for AbbVie, LEO Pharma, Menlo Therapeutics, Novartis, Pierre Fabre, Sienna Biopharmaceuticals, and Trevi; has received speaker honoraria from AbbVie, Eli Lilly, Janssen, LEO Pharma, Novartis, Sanofi-Genzyme, Sun Pharma, and Berlin-Chemie Men-narini; has served as an investigator; and has received funding from AbbVie, Amgen, Galapagos, Holm, Incyte Corporation, InflaRX, Janssen, Menlo Therapeutics, Merck, Boehringer Ingelheim, Novartis, Pfizer, Regeneron, Trevi, and UCB. Tomasz & Anna Skrzypczak report no conflict of interest.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.